Citadel Advisors’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-553
Closed -$9.74K 15366
2023
Q1
$9.74K Sell
553
-155
-22% -$7.99K ﹤0.01% 13568
2022
Q4
$36.8K Sell
708
-1,601
-69% -$116K ﹤0.01% 12510
2022
Q3
$194K Sell
2,309
-196
-8% -$26K ﹤0.01% 10432
2022
Q2
$365K Sell
2,505
-414
-14% -$60.2K ﹤0.01% 9366
2022
Q1
$451K Buy
2,919
+23
+0.8% +$5.11K ﹤0.01% 9641
2021
Q4
$797K Buy
2,896
+2,588
+840% +$1.19M ﹤0.01% 8495
2021
Q3
$201K Buy
+308
New +$271K ﹤0.01% 11975

Other funds holding NEUE

Citadel Advisors's NEUE Position: Q1 2023 in Review

Citadel Advisors sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 60 shares — an estimated $3.09K sold.

Citadel Advisors first reported a position in NEUE in Q2 2021 and held it in 6 quarters. The position peaked at $53.3M in Q2 2021. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

  • Citadel Advisors reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 60 NeueHealth shares in Q1 2023, an estimated $3.09K.
  • Citadel Advisors first reported a position in NeueHealth in Q2 2021 and held it in 6 quarters.
  • Citadel Advisors's NeueHealth position peaked at $53.3M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.